$357 Million is the total value of Eversept Partners, LP's 62 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 61.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RCM | Sell | R1 RCM INC | $33,955,420 | +18.5% | 2,699,159 | -8.9% | 9.51% | +13.7% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $30,210,880 | -29.4% | 1,558,065 | -24.4% | 8.46% | -32.2% |
| GSK | Sell | GLAXOSMITHKLINE PLCsponsored adr | $28,091,890 | -17.5% | 693,685 | -13.6% | 7.87% | -20.8% |
| ZGNX | Buy | ZOGENIX INC | $25,648,017 | -5.9% | 536,794 | +8.3% | 7.18% | -9.7% |
| DHR | Sell | DANAHER CORPORATION | $20,761,378 | -1.1% | 145,104 | -8.6% | 5.81% | -5.0% |
| ENSG | Buy | ENSIGN GROUP INC | $17,401,664 | +112.9% | 305,483 | +91.5% | 4.87% | +104.3% |
| RDUS | Buy | RADIUS HEALTH INC | $17,308,194 | +34.5% | 710,517 | +10.1% | 4.85% | +29.1% |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $15,706,115 | +29.2% | 136,397 | +32.0% | 4.40% | +24.0% |
| EHTH | Sell | EHEALTH INC | $15,389,428 | +23.0% | 178,739 | -10.9% | 4.31% | +18.1% |
| SNY | Sell | SANOFIsponsored adr | $11,512,503 | -21.8% | 266,062 | -20.0% | 3.22% | -24.9% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $10,608,350 | +50.9% | 57,849 | +51.3% | 2.97% | +44.9% |
| TGTX | Buy | TG THERAPEUTICS INC | $7,642,284 | +27.0% | 883,501 | +18.0% | 2.14% | +21.9% |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $6,883,004 | +18.4% | 305,233 | +21.9% | 1.93% | +13.6% |
| ARGX | Buy | ARGENX SEsponsored adr | $6,833,217 | +39.2% | 48,264 | +22.7% | 1.91% | +33.6% |
| ILMN | New | ILLUMINA INC | $6,733,464 | – | 18,290 | +100.0% | 1.89% | – |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $6,322,878 | – | 87,140 | +100.0% | 1.77% | – |
| BOLD | New | AUDENTES THERAPEUTICS INC | $6,039,654 | – | 159,526 | +100.0% | 1.69% | – |
| NUVA | Sell | NUVASIVE INC | $5,373,855 | -71.4% | 91,798 | -72.2% | 1.50% | -72.5% |
| CNC | Buy | CENTENE CORP DEL | $5,223,024 | +316.8% | 99,600 | +322.0% | 1.46% | +299.7% |
| ZGNX | New | ZOGENIX INCcall | $4,983,454 | – | 104,300 | +100.0% | 1.40% | – |
| ARQL | Sell | ARQULE INC | $4,973,085 | +60.5% | 451,688 | -30.2% | 1.39% | +54.1% |
| FATE | Sell | FATE THERAPEUTICS INC | $4,422,477 | -28.1% | 217,856 | -37.8% | 1.24% | -31.0% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $4,309,364 | +26.9% | 73,501 | -2.9% | 1.21% | +21.9% |
| DERM | Buy | DERMIRA INC | $3,822,795 | +57.2% | 399,874 | +122.8% | 1.07% | +50.7% |
| TCDA | Buy | TRICIDA INC | $3,455,433 | +80.7% | 87,568 | +76.9% | 0.97% | +73.5% |
| MGNX | New | MACROGENICS INC | $3,234,872 | – | 190,623 | +100.0% | 0.91% | – |
| HSKA | Buy | HESKA CORP | $2,974,477 | +423.1% | 34,924 | +422.8% | 0.83% | +401.8% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $2,972,610 | +46.1% | 117,309 | +12.4% | 0.83% | +40.1% |
| MYOK | Buy | MYOKARDIA INC | $2,840,531 | +55.9% | 56,652 | +61.6% | 0.80% | +49.4% |
| ANTM | New | ANTHEM INC | $2,822,100 | – | 10,000 | +100.0% | 0.79% | – |
| HUM | New | HUMANA INC | $2,658,140 | – | 10,000 | +100.0% | 0.74% | – |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $2,515,380 | -74.7% | 16,554 | -80.2% | 0.70% | -75.8% |
| GHDX | New | GENOMIC HEALTH INC | $2,233,903 | – | 38,403 | +100.0% | 0.63% | – |
| XENE | XENON PHARMACEUTICALS INC | $2,211,992 | -3.0% | 224,340 | 0.0% | 0.62% | -6.9% | |
| PTCT | Sell | PTC THERAPEUTICS INC | $2,187,000 | -42.2% | 48,600 | -51.7% | 0.61% | -44.6% |
| MDCO | Sell | MEDICINES CO | $2,086,084 | -2.1% | 57,200 | -24.9% | 0.58% | -6.0% |
| COLL | New | COLLEGIUM PHARMACEUTICAL INC | $1,854,150 | – | 141,000 | +100.0% | 0.52% | – |
| ZGNX | New | ZOGENIX INCput | $1,739,192 | – | 36,400 | +100.0% | 0.49% | – |
| BDSI | New | BIODELIVERY SCIENCES INTL IN | $1,656,674 | – | 356,274 | +100.0% | 0.46% | – |
| TLGT | Buy | TELIGENT INC NEW | $1,628,735 | -45.5% | 2,584,883 | +0.4% | 0.46% | -47.6% |
| SBRA | New | SABRA HEALTH CARE REIT INC | $1,547,634 | – | 78,600 | +100.0% | 0.43% | – |
| OHI | New | OMEGA HEALTHCARE INVS INC | $1,521,450 | – | 41,400 | +100.0% | 0.43% | – |
| LTC | New | LTC PPTYS INC | $1,508,013 | – | 33,027 | +100.0% | 0.42% | – |
| CTRE | Buy | CARETRUST REIT INC | $1,498,529 | +53.4% | 62,464 | +51.4% | 0.42% | +47.4% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS | $1,297,923 | -61.4% | 342,460 | -17.1% | 0.36% | -63.0% |
| IVC | Buy | INVACARE CORP | $1,091,369 | +64.9% | 210,283 | +165.9% | 0.31% | +58.5% |
| AFMD | AFFIMED N V | $924,631 | -31.7% | 322,171 | 0.0% | 0.26% | -34.4% | |
| PRVB | New | PROVENTION BIO INC | $891,298 | – | 73,661 | +100.0% | 0.25% | – |
| OPTN | New | OPTINOSE INC | $744,150 | – | 105,106 | +100.0% | 0.21% | – |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $738,905 | -24.2% | 69,708 | 0.0% | 0.21% | -27.1% | |
| AKRXQ | New | AKORN INC | $677,946 | – | 131,640 | +100.0% | 0.19% | – |
| DRNA | DICERNA PHARMACEUTICALS INC | $646,916 | +7.5% | 41,074 | 0.0% | 0.18% | +2.8% | |
| FOMX | Sell | FOAMIX PHARMACEUTICALS LTD | $626,868 | -43.3% | 263,390 | -10.6% | 0.18% | -45.3% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $603,559 | -57.6% | 84,296 | -21.4% | 0.17% | -59.4% |
| ALBO | ALBIREO PHARMA INC | $581,255 | +0.1% | 18,029 | 0.0% | 0.16% | -3.6% | |
| SVRA | New | SAVARA INC | $573,879 | – | 242,143 | +100.0% | 0.16% | – |
| SCPH | New | SCPHARMACEUTICALS INC | $556,007 | – | 174,297 | +100.0% | 0.16% | – |
| PFNX | Buy | PFENEX INC | $545,724 | +16.7% | 80,968 | +7.0% | 0.15% | +12.5% |
| OTIC | Buy | OTONOMY INC | $534,680 | +12.9% | 194,429 | +8.0% | 0.15% | +8.7% |
| BCRX | New | BIOCRYST PHARMACEUTICALScall | $385,822 | – | 101,800 | +100.0% | 0.11% | – |
| CYCN | New | CYCLERION THERAPEUTICS INC | $216,691 | – | 18,925 | +100.0% | 0.06% | – |
| AQXP | AQUINOX PHARMACEUTICALS INC | $173,972 | -12.4% | 73,717 | 0.0% | 0.05% | -15.5% | |
| CNCE | Exit | CONCERT PHARMACEUTICALS INCcall | $0 | – | -2,300 | -100.0% | -0.01% | – |
| NVAX | Exit | NOVAVAX INCput | $0 | – | -145,100 | -100.0% | -0.02% | – |
| BIOS | Exit | BIOSCRIP INC | $0 | – | -123,011 | -100.0% | -0.07% | – |
| CNCE | Exit | CONCERT PHARMACEUTICALS INC | $0 | – | -47,154 | -100.0% | -0.17% | – |
| CRSP | Exit | CRISPR THERAPEUTICS AGnamen akt | $0 | – | -42,400 | -100.0% | -0.44% | – |
| CHRS | Exit | COHERUS BIOSCIENCES INC | $0 | – | -120,036 | -100.0% | -0.48% | – |
| IRWD | Exit | IRONWOOD PHARMACEUTICALS INC | $0 | – | -195,701 | -100.0% | -0.77% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS INcall | $0 | – | -43,800 | -100.0% | -1.43% | – |
| ARRY | Exit | ARRAY BIOPHARMA INC | $0 | – | -214,112 | -100.0% | -1.52% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -114,779 | -100.0% | -1.59% | – |
| ABMD | Exit | ABIOMED INC | $0 | – | -27,339 | -100.0% | -2.28% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.